Today, we take our first look at medical device concern Harvard Bioscience, Inc. The shares have doubled over the past few months on better-than-expected results and improving cash flow. Can the rally ...
The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates ...
HOLLISTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2023. Jim Green, ...
Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement. Analysts estimate that Harvard ...
Operator: Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the ...
HOLLISTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results